Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
It will be a misty and cloudy start in many southern and central parts which will slowly lift this morning.
The president-elect also warned US companies they would face "retribution" for setting up their business operations abroad.
Penalties of £100 or a court fine of up to £1,000 can now be handed to anyone caught lighting up in a private vehicle with someone under 18.